Jagsonpal Pharmaceuticals Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 83.61 | 85.07 | 67.37 |
| Operating Expense | 64.84 | 64.99 | 53.04 |
| Net Profit | 12.59 | 13.19 | 8.76 |
| Net Profit Margin | 15.06% | 15.50% | 13.00% |
| Earning Per Share | 1.91 | 2 | 1.25 |
| EBIDTA | 18.51 | 19.76 | 13.79 |
| Effective Tax Rate | 21.27% | 20.83% | 17.17% |
Particulars
Sep 2026
Revenue83.61
Operating Expense64.84
Net Profit12.59
Net Profit Margin15.06
Earning Per Share1.91
EBIDTA18.51
Effective Tax Rate21.27
